Back to Results
First PageMeta Content
Health / Growth hormone treatment / Growth hormone deficiency / Growth hormone / Saizen / Insulin tolerance test / Insulin-like growth factor 1 / Randomized controlled trial / Pituitary tumour / Growth hormones / Medicine / Endocrine system


Document Date: 2007-06-06 05:36:44

Open Document

File Size: 106,44 KB

Share Result on Facebook

City

Nottingham / London / /

Company

Lilly / ITT / Abba Litho Sales Limited / Pharmacia / Novo Nordisk / /

Country

Netherlands / United Kingdom / Spain / Wales / /

Currency

GBP / /

Event

Product Issues / /

Facility

NHS National Institute / University of Sheffield School / National Institute / Wessex Institute / /

IndustryTerm

agreed sharedcare protocol / injection site / energy level / advocacy groups / 6NA Web / health services / energy dimension / placebo / intima media / reduced energy levels / /

MedicalCondition

carpal tunnel syndrome / acute respiratory failure / mild hypertension / pituitary hormone deficiency / headache / severe growth hormone deficiency / nausea / osteopenia/osteoporosis / Adult GH deficiency / hypersensitivity / adult onset GH deficiency / severe GH deficiency / iatrogenic GH deficiency / insulin resistance / arthralgia / pituitary tumours / GH disorders / Childhood-onset GH deficiency / tumour / muscle pain / vomiting / Benign intracranial hypertension / growth hormone deficiency / deficiency / GH deficiency / joint pain / adult-onset GH deficiency / tumours / /

MedicalTreatment

cranial irradiation / chemotherapy / abdominal surgery / /

Organization

Society for Endocrinology / Wales Commission for Health Improvement NHS Clinical Governance Support Team Patient / Related Research / NHS National Institute for Clinical Excellence Human / Appraisal Committee / University of Sheffield School of Health / University of Sheffield School of Health and Related Research / National Institute for Clinical Excellence MidCity Place / Wessex Institute for Health Research and Development / NHS / National Institute for Clinical Excellence / /

Position

England Consultant / consultant / chief / Director Wales Chief Executive / Director Wales Medical & Head / Wales Consultant / Representative / pharmacists and pharmaceutical advisors / Psychological General / England Chief / /

Product

Humatrope / glucagon / Norditropin / Saizen / Genotropin / patients / /

PublishedMedium

the ScHARR review / /

Technology

agreed sharedcare protocol / 2003 Technology / growth hormone deficiency Technology / diagnostic tests / GPS / The technology / chemotherapy / 3 The technology / recombinant DNA technology / /

URL

www.nice.org.uk / /

SocialTag